Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Aug 31, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000037.pdf 0001237899-20-000037.xls
Aug 31, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000038.pdf 0001237899-20-000038.xls
Aug 31, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000039.pdf 0001237899-20-000039.xls
Aug 27, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000101.pdf 0001708138-20-000101.xls
Aug 27, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000102.pdf 0001708138-20-000102.xls
Aug 24, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-20-098009.pdf 0001104659-20-098009.xls
Aug 24, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000036.pdf 0001237899-20-000036.xls
Aug 24, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000098.pdf 0001708138-20-000098.xls
Aug 24, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000097.pdf 0001708138-20-000097.xls
Aug 19, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-20-096661.pdf 0001104659-20-096661.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

Investors & Media